Posted on December 2, 2022
Learn about Andrew Dreyfus, NEHI's 2023 Henri A. Termeer Memorial Innovator in Health awardee.
Named in honor of the late Henri A. Termeer, a biotechnology pioneer and NEHI founder, this Award recognizes an individual who has made lasting contributions to the health care sector and inspired the community with their vision and achievements.
Andrew Dreyfus is a health care executive and expert in health system change. He served from 2010 to 2022 as President and Chief Executive Officer for Blue Cross Blue Shield of Massachusetts (BCBSMA), a plan with over $8 billion in revenue and nearly three million members. Under his leadership, BCBSMA was known as an innovator on payment models, quality improvement, mental health, and health equity.
Andrew joined BCBSMA in 2005 as Executive Vice President of Health Care Services, where he led the creation of the Alternative Quality Contract, one of the largest commercial payment reform programs in the nation. He previously served as founding President of the Blue Cross Blue Shield of Massachusetts Foundation, where he oversaw the initiative that led to the passage of Massachusetts’ 2006 Health Reform Law, which later became the model for the Affordable Care Act.
Andrew serves on the board of Ironwood Pharmaceuticals, The Joint Commission, and the BCBSMA Foundation. He serves on the advisory boards of Ariadne Labs, Arsenal Capital Partners, Lumanity, SemCap Health, and Vanna Health. He is a Menschel Sr. Leadership Fellow with Harvard University’s School of Public Health. Over the last two decades, Andrew has helped lead the creation of several collaborative health organizations in Massachusetts, including the Schwartz Center for Compassionate Care, Massachusetts Health Quality Partners, the Massachusetts Coalition for the Prevention of Medical Errors, and the Massachusetts Coalition for Serious Illness Care.